Chandan Healthcare, a prominent diagnostics company in North India, is set to raise ₹104 crore through a preferential issue of warrants. This financial maneuver coincides with an exclusive nationwide partnership with Jeena Sikho Lifecare Limited, a leading Ayurvedic healthcare provider.
The Board of Directors at Chandan Healthcare has approved the issuance of up to 44.50 lakh fully convertible equity warrants at a price of ₹234 per warrant, amounting to approximately ₹104 crore. Each warrant can be converted into one fully paid-up equity share.
The initiative has been designed to attract both participation from the promoter group and strategic institutional investors. Specifically, 4.75 lakh warrants will be allotted to the promoters, while the remaining 39.75 lakh will go to non-promoters.
In a strategic move, Chandan Healthcare has entered an exclusive partnership with Jeena Sikho Lifecare to establish diagnostic centres within all existing and future Jeena Sikho hospitals and clinics throughout India. As the exclusive diagnostic partner, Chandan will operate across 23 states and over 100 cities, providing comprehensive pathology and radiology solutions for patients.
The partnership aims to enhance access to high-quality, affordable, and technology-enabled diagnostic services across the nation, aligning with the missions of both organizations. Amar Singh, Promoter and Managing Director of Chandan Healthcare, emphasized that the strong interest from investors reflects a robust confidence in the company’s business model and growth strategy.
A significant portion of the funds raised will be directed toward expansion efforts, including the establishment of new diagnostic laboratories, upgrading existing infrastructure, and bolstering working capital to support the company’s rapidly growing operations.
Jeena Sikho Lifecare manages an extensive network, comprising 55 hospitals and 74 clinics/daycare centers across 21 states and over 100 cities, with more than 1,500 operational beds. Currently, Chandan Healthcare boasts 40 diagnostic centres and over 360 collection points.
Following this announcement, Chandan Healthcare’s shares increased by 5 percent, reaching ₹302.
Published on October 13, 2025.
